Stock CRVS CORVUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Corvus Pharmaceuticals, Inc.

Equities

CRVS

US2210151005

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
2.08 USD +2.46% Intraday chart for Corvus Pharmaceuticals, Inc. +8.33% +18.18%
May. 07 Corvus Pharmaceuticals Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing MT
May. 07 Oppenheimer Adjusts Price Target on Corvus Pharmaceuticals to $8 From $7, Maintains Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CORVUS PHARMACEUTICALS, INC. Stock Corvus Pharmaceuticals, Inc.
 102M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 44.96B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.65B
LONZA GROUP AG Stock Lonza Group AG
 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.08B
  1. Stock Market
  2. Equities
  3. CRVS Stock
  4. Charts Corvus Pharmaceuticals, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW